Global Venous Stents Market Set for Strong Growth, Reaching USD 2.6 Billion by 2035

The global venous stents market is entering a period of strong and sustained expansion. Valued at USD 1.2 billion in 2025, the industry is expected to reach USD 2.6 billion by 2035, reflecting a steady compound annual growth rate (CAGR) of 8.4%. This surge is attributed to the increasing prevalence of venous disorders such as deep vein thrombosis (DVT), post-thrombotic syndrome, and chronic venous obstructions, alongside innovations in minimally invasive vascular treatments.

Hospitals, specialty clinics, and healthcare systems are progressively adopting venous stents as frontline solutions for restoring venous flow, alleviating symptoms, and reducing long-term complications. As a result, the market now represents 8.5% of the broader global stents market and is positioned as one of the fastest-growing subsegments.

Why the Market Is Growing

The rationale behind this robust growth lies in both epidemiological and technological factors. The aging global population, rising obesity rates, and sedentary lifestyles are directly contributing to the increased incidence of venous diseases. According to the World Health Organization, cardiovascular diseases account for nearly 17.9 million deaths annually, with venous conditions playing a critical role in this statistic.

Full Market Report available for delivery. For purchase or customization, please request here: https://www.futuremarketinsights.com/reports/sample/rep-gb-17110

At the same time, continuous advancements in stent technology are shaping the treatment landscape. New designs, improved biocompatibility, and enhanced imaging techniques are leading to safer, more effective, and longer-lasting outcomes. For patients, this means quicker recovery times and reduced hospital stays, while healthcare providers benefit from lower complication rates and improved procedural efficiency.

Segmental Insights: Why Nitinol and Braided Stents Lead

Among material categories, Nitinol stents dominate the venous stent landscape, accounting for 57.3% of market share in 2025. The nickel-titanium alloy's flexibility, shape memory, and resistance to fatigue make it uniquely suited to the dynamic environment of venous applications. These properties allow Nitinol stents to adapt seamlessly to vascular conditions, reducing risks of restenosis and ensuring long-term durability.

From a design perspective, braided stents are projected to contribute nearly half of total revenues, with a market share of 49.6% in 2025. Their adaptability to complex anatomies, strong radial support, and ease of deployment are winning over physicians worldwide. This design also reduces migration risks, reinforcing trust among interventional specialists seeking reliable solutions.

Key Indications Driving Adoption

Chronic deep vein thrombosis (DVT) remains the most dominant indication, representing 44.8% of revenues in 2025. With hundreds of thousands of new cases diagnosed annually, and with DVT often linked to long-term complications such as swelling and pain, demand for stenting solutions continues to climb.

Beyond DVT, venous stents are increasingly being used to address chronic venous insufficiency, post-thrombotic syndrome, and other related conditions. The market is also benefiting from better patient awareness and improved diagnostics, leading to earlier intervention and treatment.

Regional Dynamics: Growth Across Continents

North America leads the global market, with the United States alone accounting for 32.8% of total value in 2025. Each year, nearly 900,000 Americans suffer from DVT or pulmonary embolism, driving significant demand for advanced venous stent therapies. Rising healthcare expenditure, projected to surpass USD 6.2 trillion by 2035, will further expand access to these critical procedures.

In Europe, Germany stands out with 4.4% share of the global market in 2025. The country's high incidence of venous diseases and strong healthcare infrastructure are fueling demand. Meanwhile, the United Kingdom and France are also experiencing notable growth, influenced by rising awareness around early treatment of venous disorders.

Asia-Pacific is emerging as the fastest-growing region, with China holding 6.3% share in 2025 and projected to grow rapidly due to its large patient base and increased adoption of interventional procedures. India, with 3.6% share, is also attracting global manufacturers who are expanding into this highly lucrative market. With tier-1 and tier-2 cities showing sharp increases in demand, India represents one of the most promising frontiers for long-term growth.

Opportunities for Manufacturers

For global manufacturers, the venous stents market presents an array of opportunities. Rising cardiovascular disease cases, especially in aging populations, are creating sustained demand. Obesity, a major risk factor for venous disease, is also on the rise globally, further fueling the need for effective interventions.

Emerging opportunities lie in:

- Smart material innovation for enhanced flexibility and biocompatibility.
- Strategic acquisitions and partnerships, enabling rapid geographic expansion.
- Cost-effective stent solutions tailored to emerging markets with budget-conscious healthcare systems.
- Integration of advanced imaging and interventional techniques to improve procedural outcomes.

Global players such as Becton, Dickinson and Company, Boston Scientific, Medtronic, Abbott, and Philips are leading this transformation, alongside innovative mid-tier manufacturers such as Optimed Medizinische Instrumente GmbH and plus medica GmbH & Co. KG. Their combined focus on technology development and market expansion is reshaping treatment standards worldwide.

Request Market Research Draft Report: https://www.futuremarketinsights.com/reports/venous-stents-market

Challenges Facing the Industry

Despite the positive trajectory, the industry faces challenges that manufacturers and healthcare providers must navigate. The high cost of venous stent procedures remains a barrier, particularly in developing markets. Skilled professionals trained in stent implantation are also in short supply in several regions, limiting access to advanced treatments.

Another concern lies in product safety. Recalls, such as the 2020 withdrawal of 7,000 venture catheters by Vascular Solutions due to risks of blood clots, highlight the critical importance of rigorous quality control. Manufacturers that can guarantee safety and reliability while keeping costs competitive will be best positioned to gain long-term trust.

Competitive Landscape: Established Leaders and New Entrants

The competitive landscape is defined by both established leaders and ambitious newcomers. Large global players such as Boston Scientific, Medtronic, Abbott, and Becton Dickinson continue to dominate through broad portfolios and international reach. However, smaller innovators and regional companies are carving out niches by focusing on specialized stent designs, cost competitiveness, and faster regulatory approvals.

Recent moves underscore the dynamic nature of the sector. In May 2025, Becton Dickinson relaunched its Venovo venous stent in the U.S. market following an earlier recall, reaffirming its commitment to quality improvements. In December 2024, Philips strengthened its presence by acquiring Vesper Medical, a U.S.-based innovator in venous stent technology, enhancing its ability to offer advanced solutions for deep vein disease.

Related Reports:

Cataract Surgery Devices Market: https://www.futuremarketinsights.com/reports/cataract-surgery-devices-market

Skin Replacement Market: https://www.futuremarketinsights.com/reports/skin-replacement-market

Dental Chairs Market: https://www.futuremarketinsights.com/reports/dental-chairs-market

Contact Us:

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.